PF4-heparin antibodies during ECMO: incidence, course, and outcomes

Intensive Care Med. 2016 Jun;42(6):1082-3. doi: 10.1007/s00134-016-4262-2. Epub 2016 Feb 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / adverse effects*
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Heparin / adverse effects*
  • Humans
  • Immunoassay
  • Male
  • Middle Aged
  • Platelet Factor 4 / immunology*
  • Prospective Studies
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / immunology

Substances

  • Anticoagulants
  • Platelet Factor 4
  • Heparin